EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities

Matthias Van Hul iD, Audrey M Neyrinck, Amandine Everard, Anne Abot, Laure B Bindels, Nathalie M Delzenne, Claude Knauf, Patrice D Cani iD

Clinical Microbiology Reviews · 12.09.2024 · 37 (3)

DOI: 10.1128/cmr.00045-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.09.2024. Verfasst von Matthias Van Hul und 7 weiteren Autor:innen. Beteiligte Einrichtung: UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute (LDRI), Metabolism and Nutrition Research Group (MNUT), Brussels, Belgiu…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Obesity. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fonds De La Recherche Scientifique - FNRS (FNRS), Walloon excellence in life sciences and biotechnology (WELBIO), 'la Caixa' Foundation ('la Caixa').

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota is a major factor contributing to the regulation of energy homeostasis and has been linked to both excessive body weight and accumulation of fat mass (i.e., overweight, obesity) or body weight loss, weakness, muscle atrophy, and fat depletion (i.e., cachexia). These syndromes are characterized by multiple metabolic dysfunctions including abnormal regulation of food reward and intake, energy storage, and low-grade inflammation. Given the increasing worldwide prevalence of obesity, cachexia, and associated metabolic disorders, novel therapeutic strategies are needed. Among the different mechanisms explaining how the gut microbiota is capable of influencing host metabolism and energy balance, numerous studies have investigated the complex interactions existing between nutrition, gut microbes, and their metabolites. In this review, we discuss how gut microbes and different microbiota-derived metabolites regulate host metabolism. We describe the role of the gut barrier function in the onset of inflammation in this context. We explore the importance of the gut-to-brain axis in the regulation of energy homeostasis and glucose metabolism but also the key role played by the liver. Finally, we present specific key examples of how using targeted approaches such as prebiotics and probiotics might affect specific metabolites, their signaling pathways, and their interactions with the host and reflect on the challenges to move from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeObesityHumansAnimalsComorbidityEnergy MetabolismHomeostasisProbioticsInflammationCachexia

Stichwörter der Autor:innen

cancer cachexiagut barriergut microbiotainflammationnutritionobesityprebioticsprobiotics

Autor:innen und Institutionen

  • UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute (LDRI), Metabolism and Nutrition Research Group (MNUT), Brussels, Belgium.
  • Walloon Excellence in Life Sciences and BIOtechnology (WELBIO), WELBIO department, WEL Research Institute, Wavre, Belgium.
  • NeuroMicrobiota, International Research Program (IRP) INSERM/UCLouvain, France/Belgium.
  • Enterosys SAS, Labège, France.
  • INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), Université Paul Sabatier, Toulouse III, CHU Purpan, Toulouse, France.
  • UCLouvain, Université catholique de Louvain, Institute of Experimental and Clinical Research (IREC), Brussels, Belgium.

ORCID-Profile: Matthias Van Hul, Patrice D Cani

Förderung

  • Fonds De La Recherche Scientifique - FNRS (FNRS)
  • Walloon excellence in life sciences and biotechnology (WELBIO)
  • 'la Caixa' Foundation ('la Caixa')
  • FRS-FNRS (Fonds de la Recherche Scientifique) - FNRS

Zitieren

APA

Van Hul, M., Neyrinck, A. M., Everard, A., Abot, A., Bindels, L. B., Delzenne, N. M., Knauf, C., & Cani, P. D. (2024). Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities. Clinical Microbiology Reviews, 37(3). https://doi.org/10.1128/cmr.00045-23

Vancouver

Van Hul M, Neyrinck AM, Everard A, Abot A, Bindels LB, Delzenne NM, et al. Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities. Clinical Microbiology Reviews. 2024;37(3). doi:10.1128/cmr.00045-23

BibTeX
@article{VanHul2024,
  author = {Van Hul, Matthias and Neyrinck, Audrey M and Everard, Amandine and Abot, Anne and Bindels, Laure B and Delzenne, Nathalie M and Knauf, Claude and Cani, Patrice D},
  title = {Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  volume = {37},
  number = {3},
  doi = {10.1128/cmr.00045-23}
}
Kostenlos starten →